Biocept Revenue
Biotechnology Research • 
San Diego, California, United States • 21-50 Employees
Biocept revenue & valuation
| Annual revenue | $98,300,000 |
| Revenue per employee | $2,092,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $314,500,000 |
| Total funding | $5,000,000 |
Key Contacts at Biocept
Randy Goodman
Director Of Managed Care Payer Relations, Health Economics & Outcomes Research
Bill Hutsell
Regional Sales Director
Dede Goehler
Senior Director Managed Care
Farideh Bischoff
Sr. Director, Translational Research And Clia Development
Mariko Matsutani
Associate Director
Company overview
| Headquarters | 9955 Mesa Rim Road, San Diego, California 92121, US |
| Phone number | +18583208200 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Melanoma, Prostate Cancer, Diagnostic Products, Testing Services, Laboratory Testing, Cancer Diagnostics, Clinical Services, Clinical Testing, Molecular Testing, Gastric Cancer, Liquid Biopsy, Oncology Testing, Ctdna, Colorectal Cancer, Ctc Testing, Cancer Diagnostic Development, Metastatic Breast Cancer, Non-Small Cell Lung Cancer |
| Founded | 1993 |
| Employees | 21-50 |
| Socials |
Biocept Email Formats
Biocept uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
About Biocept
Biocept, Inc. (Nasdaq: BIOC) develops and performs clinical laboratory tests to help patients with cancer that has metastasized to the central nervous system (CNS). Our CNSide™ assay provides enhanced detection and analysis of tumor cells and cell-free DNA from cerebrospinal fluid (CSF). Quantitative results help evaluate a patient’s response to treatment. Additional biomarkers can characterize genetic changes associated with therapy resistance and identify new options for treating CNS metastasis. CNSide results from Biocept’s CLIA-certified and CAP-accredited laboratory help oncologists manage one of the most difficult complications of cancer, answering three critical questions: Is there tumor in the CSF? Is there a target for treatment? Is there a trend in treatment response? The Biocept team is dedicated to improving care for cancer patients – which means making a difference in people’s lives, every day. Biocept also provides RT-PCR based COVID-19 testing to support state and national public health efforts.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Biocept has 14 employees across 6 departments.
Departments
Number of employees
Biocept Tech Stack
Discover the technologies and tools that power Biocept's digital infrastructure, from frameworks to analytics platforms.
CDN
Australia
Frequently asked questions
4.8
40,000 users
